London
18 °C
Manchester
16 °C
Glasgow
Dublin
Belfast
Washington
Denver
21 °C
Atlanta
Dallas
Houston Texas
33 °C
New Orleans
El Paso
Phoenix
Los Angeles
17 °C
2 °C
29 °C
3 °C
22 °C
22 °C
Featured
Last news
'Unfinished business': Opponents anxious, bitter after Iran ceasefire
President Donald Trump promised "regime change" in Iran but the Islamic republic has emerged intact from the US-Israeli war, leaving opponents and activists disappointed and frightened.
SerenaGroup Launches National HBOT Consulting Service to Help Hospitals Reclaim Control of Wound Care Programs
CAMBRIDGE, MA / ACCESS Newswire / April 8, 2026 / Hospitals face mounting pressure to improve outcomes while reducing costs. SerenaGroup® has a novel solution for Wound Care and Hyperbaric Oxygen Services: Consulting Services. The goal is to improve outcomes and increase profitability without outsourcing operational control.
Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)
Beverly Hills spine surgeons complete three-level cervical disc replacement following recent FDA approval of motion-preserving technology
Dalet Announces Commercial Availability of Dalia, Bringing Media-Aware Agentic AI to Enterprise Productions
Dalia's conversational UX and a multi-agent intelligence framework enable customers to operationalize AI across production, archive, and publishing workflows while keeping humans in the loop.
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Topline results expected within a month and may complement positive results of a study of crofelemer for treatment of cancer therapy-induced diarrhea (CTD) in dogs receiving neratinib - a targeted tyrosine kinase inhibitor (TKI)
Envision Pharma Group appoints Nick Jones as President, Envision Medical Communications
Seasoned technology and life sciences leader to advance AI integration across medical communications
Trump suspends Iran bombing for two weeks, after apocalyptic threats
US President Donald Trump said Tuesday he was suspending bombing of Iran for two weeks but that Tehran must reopen the key Strait of Hormuz, barely an hour before his apocalyptic deadline to destroy the country was set to expire.
Graft trial of Spanish PM's ex-top aide begins
A corruption trial of Spanish Prime Minister Pedro Sanchez's former right-hand man opened on Tuesday, a case that has rocked a Socialist-led minority government that has prioritised stamping out graft.
French high-speed train slams into truck, killing TGV driver
A French high-speed train crashed into a truck carrying a military vehicle in northern France on Tuesday, killing the driver of the TGV and badly injuring two people, officials said.
Gunman killed, 2 wounded in shootout outside Israel's Istanbul consulate
A gunman was killed and two others wounded in a shootout Tuesday with police outside the Israeli consulate in Istanbul, the local governor said, adding two officers were lightly wounded.
Train driver killed, two critically injured as French TGV collides with truck
A French high-speed train crashed into a truck carrying military equipment in northern France on Tuesday, killing the driver of the TGV and critically injuring two people, officials said.
New strikes in Tehran as deadline looms for Trump threat to infrastructure
New strikes rocked Tehran on Tuesday with Iran showing no sign of backing down as a US deadline loomed for it to reopen the Strait of Hormuz or have its civilian infrastructure "decimated", according to President Donald Trump.
Olympic cyclist Rohan Dennis breaks silence after wife's death
Australian former world champion cyclist Rohan Dennis said on Tuesday he loved his wife and never wanted to hurt her in his first public comments since receiving a suspended sentence over her death.
Most Men Wait Years to See a Specialist - At Starke Medical Group, They Can Reach One Right Now
Houston Physician Dr. Nathan Starke Launches a Concierge Practice Built Around House Calls, Telemedicine, 24/7 Direct Access for Patients of All Genders - No Waiting Rooms. Ever.
T-REX Acquisition Corp. (OTCQB:TRXA) Completes Strategic Refinancing of Orofino, Idaho Data Center
Positions Company for Expansion Across Crypto Infrastructure, Mining Operations, and Modular Deployment Solutions
New to The Street Resigns Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) to Continue Long-Form Interview Series, Outdoor Media Campaigns and Accredited Investor Events
Three Consecutive Years of Ongoing Predictable Media™ Partnership
Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
SHELTON, CT / ACCESS Newswire / April 7, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that it has filed an application for "Rare Pediatric Disease Drug" Designation (RPDD) for NV-387 as a Treatment for Measles with the US FDA Office of Orphan Products Development (OOPD). This RPDD application is expected to be joined together with the Orphan Drug Designation application for NV-387 as a Treatment for Measles that the Company has filed in February, 2026.
New to The Street Signs Medicus Pharma Ltd. (NASDAQ:MDCX) to Transformational 12-Part National Media Series Highlighting SkinJect(TM) and Teverelix(R) Platforms
NEW YORK CITY, NY / ACCESS Newswire / April 7, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX), a precision-guided biotech and life sciences company advancing innovative therapeutic platforms, has entered into a 12-part, one-year strategic media agreement with New to The Street to expand its national and international visibility across television, digital, and outdoor platforms.
Jaguar Health Reports 2025 Financials
Net revenue increase of 5% in Q4 2025 vs. Q3 2025Jaguar received an up-front payment of $16Mof non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1 - Jaguar's commercialized crofelemer drugs - with an additional $2 million due upon completion of post-closing conditions; and has received $3.0 of up to $20 million in milestone payments and other future paymentsAgreement with Future Pak is fully aligned with Jaguar's strategy to concentrate crofelemer development efforts on human rare-disease intestinal failure indications moving forwardJaguar will appeal Nasdaq's March 5, 2026 noncompliance determination related to Nasdaq Listing Rule 5550(a)(2) at a hearing on April 7, 2026; delisting is stayed pending the panel's final decisionREMINDER: Friday, April 10, Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q4 2025 financials and company updates; Click here to register
Trump says Iran ceasefire proposal 'not good enough'
US President Donald Trump said Monday that a proposed 45-day ceasefire with Iran was a "very significant step" but "not good enough" for him to sign, as Iranian officials vowed to keep fighting.
In El Salvador's mass trials, 'the innocent pay for the guilty'
Wearing white uniforms, their heads shaved, rows of bewildered-looking men are beamed by video link from prisons across El Salvador into a courtroom conducting a mass trial of alleged gang members.
Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010, its investigational seasonal influenza vaccine, and for mRESVIA® (mRNA-1345), its mRNA respiratory syncytial virus (RSV) vaccine, at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, Germany, on April 17-21, 2026.
NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study
LEXINGTON, KY / ACCESS Newswire / April 6, 2026 / NX Development Corp (NXDC) is pleased to announce that after successfully completing the data analysis of our MEN-301 Study of the use of Gleolan® (aminolevulinic acid HCl) to enhance visualization of newly diagnosed or recurrent meningioma, we have submitted these data to the FDA for review as part of an efficacy supplement to our Gleolan New Drug Application (NDA).
Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update
NEW YORK CITY, NY / ACCESS Newswire / April 6, 2026 / Emerging Growth Research today announced the release of its Quarterly Update Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's closing price of $4.47 on April 3, 2026.
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced formation of an Acute Kidney Injury (AKI) Advisory Board for the upcoming Phase 2/3 AKI clinical trial. This distinguished panel brings together internationally recognized Nephrologists and Critical Care Physicians who will guide the company's clinical strategy, monitor progress, and ensure the initiative achieves the goal of improving patient care by advancing Gemini for the treatment of AKI. Their collective insight will help inform the most pertinent study design to best address the significant unmet medical need in AKI.
'Choose peace': Pope marks first Easter under cloud of Mideast war
Pope Leo XIV on Sunday urged "those who have the power to unleash wars" to "choose peace" in in his first Easter blessing as pontiff with the Middle East conflict raging.
Afghan mother seeks justice after Pakistani bombing kills hundreds
Samira Muhammadi hopes an international investigation can "extinguish" her pain after a Pakistani bombing killed her son and hundreds of other Afghans in the capital Kabul last month.
UK royal family's dilemma over Andrew's daughters
The downfall of the former prince Andrew has left the British monarchy with a right royal headache -- how to handle his daughters caught up in the scandal of US sex offender Jeffrey Epstein.
Pope marks first Easter under cloud of Mideast war
Pope Leo XIV is set to mark Easter Sunday for the first time as pontiff, with the Middle East war casting a pall over the most important date in the Christian calendar.
Police arrest suspect in Jewish ambulance arson case in court
London police announced Saturday they had arrested another man over an arson attack on ambulances run by a Jewish charity in London -- after officers recognised him at a court hearing over the incident.
Rain, storms kill 121 in Afghanistan and Pakistan in two weeks
Heavy rain and storms have killed at least 121 people over two weeks across Afghanistan and Pakistan, disaster officials in both countries said Saturday.
Belgian prison tour lays bare grim reality of life behind bars
As Belgium grapples with chronic prison overcrowding, a local charity in Brussels has found an immersive way to highlight the problem -- giving educational tours of a recently abandoned jail.